Showing results (1681-1690 of 2,048) with videos related to

Sort By:
Pageof 205
Future Oncology (London, England)|December 10, 2025
Nivolumab plus brentuximab vedotin for relapsed/refractory diffuse large B-cell lymphomaNathalie A Johnson, Pier Luigi Zinzani, Eva Domingo-Domenech, et al.
Heart Failure Reviews|August 11, 2024
The utility of urine sodium-guided diuresis during acute decompensated heart failureHasan K Siddiqi, Zachary L Cox, Lynne W Stevenson, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|June 20, 2018
Core outcome sets for prevention and treatment of postpartum haemorrhage: an international Delphi consensus studyS Meher, A Cuthbert, J J Kirkham, et al.
Journal of the American College of Cardiology|June 11, 2025
Predicting Heart Failure Outcomes Using Patient-Reported Health Status: Real-World Validation of the KCCQ-12Bassim R El-Sabawi, Mohammed A Al-Garadi, Bryan D Steitz, et al.
American Heart Journal|July 29, 2014
Designing effective drug and device development programs for hospitalized heart failure: a proposal for pretrial registriesStephen J Greene, Ami N Shah, Javed Butler, et al.
MMWR. Morbidity and Mortality Weekly Report|September 23, 2021
Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2021Kathleen Dooling, Julia W Gargano, Danielle Moulia, et al.
American Journal of Therapeutics|July 23, 2008
Design and rationale of the URGENT Dyspnea study: an international, multicenter, prospective studyPeter S Pang, Miguel Tavares, Sean P Collins, et al.
Hematological Oncology|August 7, 2019
A phase II study to assess the safety and efficacy of the dual mTORC1/2 inhibitor vistusertib in relapsed, refractory DLBCLToby A Eyre, Catherine Hildyard, Angela Hamblin, et al.
The New England Journal of Medicine|November 1, 2018
CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin's LymphomaRanjana Advani, Ian Flinn, Leslie Popplewell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 13, 2019
Outcomes of Immunocompromised Adults Hospitalized With Laboratory-confirmed Influenza in the United States, 2011-2015Jennifer P Collins, Angela P Campbell, Kyle Openo, et al.
Pageof 205